W.G. Shaheen & Associates DBA Whitney & Co lifted its position in shares of Rentokil Initial plc (NYSE:RTO – Free Report) by 26.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 202,976 shares of the company’s stock after buying an additional 43,041 shares during the quarter. W.G. Shaheen & Associates DBA Whitney & Co’s holdings in Rentokil Initial were worth $6,018,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new position in Rentokil Initial during the fourth quarter worth about $77,547,000. Lazard Asset Management LLC lifted its stake in Rentokil Initial by 345,196.7% in the 1st quarter. Lazard Asset Management LLC now owns 1,560,741 shares of the company’s stock valued at $47,056,000 after buying an additional 1,560,289 shares in the last quarter. Gates Capital Management Inc. grew its holdings in Rentokil Initial by 11.4% during the 4th quarter. Gates Capital Management Inc. now owns 5,155,193 shares of the company’s stock valued at $147,490,000 after buying an additional 528,409 shares during the last quarter. Bar Harbor Wealth Management purchased a new position in Rentokil Initial during the first quarter worth $8,528,000. Finally, Schroder Investment Management Group raised its holdings in shares of Rentokil Initial by 13.8% in the fourth quarter. Schroder Investment Management Group now owns 2,025,479 shares of the company’s stock worth $57,949,000 after acquiring an additional 246,253 shares during the last quarter. Institutional investors and hedge funds own 9.91% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. Sanford C. Bernstein upgraded shares of Rentokil Initial from an “underperform” rating to a “market perform” rating in a report on Monday, July 22nd. Barclays upgraded Rentokil Initial to a “strong-buy” rating in a report on Friday, July 26th. Finally, UBS Group upgraded Rentokil Initial from a “sell” rating to a “neutral” rating in a report on Monday, July 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $29.00.
Rentokil Initial Trading Down 0.1 %
Shares of RTO opened at $32.23 on Friday. The company’s fifty day moving average is $30.73 and its two-hundred day moving average is $29.07. Rentokil Initial plc has a fifty-two week low of $23.39 and a fifty-two week high of $38.43.
Rentokil Initial Cuts Dividend
The company also recently declared a semi-annual dividend, which will be paid on Tuesday, September 17th. Shareholders of record on Friday, August 9th will be given a dividend of $0.2034 per share. This represents a yield of 1.7%. The ex-dividend date of this dividend is Friday, August 9th.
Rentokil Initial Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
- Five stocks we like better than Rentokil Initial
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- The 3 Best Blue-Chip Stocks to Buy Now
- MarketBeat Week in Review – 8/26 – 8/30
Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial plc (NYSE:RTO – Free Report).
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.